Prevalence of Endolymphatic Hydrops With a Hitory of Congenital Cytomegalovirus Infection — HYDROPS-CMV  

Endolymphatic Hydrops Clinical Trial

Official title: Prevalence of Endolymphatic Hydrops in Patients With a History of Congenital Cytomegalovirus Infection With Symptomatic Cochleo-vestibular Involvement

Status Recruiting

Clinical Trial Summary

The management of patients with a history of congenital CMV infection (whether symptomatic or asymptomatic at birth) is modeled on their usual management.

Clinical Trial Description

The management of patients with a history of congenital CMV infection (whether symptomatic or asymptomatic at birth) is modeled on their usual management. Patients benefit as part of the care: - A clinical cochleo-vestibular examination - Functional otoneurological explorations: audiogram, caloric tests, vHIT, otolithic evoked potentials - From an uninjected brain MRI Participation in this research entails the addition of an MRI sequence and an injection of contrast product (Gadovist®): - 3D FLAIR MRI sequence dedicated to the exploration of the inner ear, lasting 6min30s, performed 4 hours after the initial injection of contrast product. ;

Related Conditions & MeSH terms

• Cytomegalovirus Infections
• Edema
• Endolymphatic Hydrops

• NCT number: NCT05229744
• Study type: Observational
• Source: Fondation Ophtalmologique Adolphe de Rothschild
• Contact: amélie YAVCHITZ
• Phone: 0148036454
• Email: ayavchitz@for.paris
• Status: Recruiting
• Start date: December 15, 2022
• Completion date: September 15, 2025